Uniunea Europeană -
română -
EMA (European Medicines Agency)
sugammadex piramal
piramal critical care b.v. - sugammadex sodium - blocaj blocant - sugammadex - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.
Uniunea Europeană -
română -
EMA (European Medicines Agency)
sugammadex mylan
mylan ireland limited - sugammadex sodium - blocaj blocant - toate celelalte produse terapeutice - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Uniunea Europeană -
română -
EMA (European Medicines Agency)
sugammadex fresenius kabi
fresenius kabi deutschland gmbh - sugammadex sodium - blocaj blocant - toate celelalte produse terapeutice - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Uniunea Europeană -
română -
EMA (European Medicines Agency)
sugammadex amomed
aop orphan pharmaceuticals gmbh - sugammadex sodium - blocaj blocant - toate celelalte produse terapeutice - inversarea blocadei neuromusculare indusă de rocuroniu sau vecuroniu. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Uniunea Europeană -
română -
EMA (European Medicines Agency)
sugammadex adroiq
extrovis eu ltd. - sugammadex sodium - blocaj blocant - toate celelalte produse terapeutice - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Republica Moldova -
română -
AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)
sugammadex rompharm 100 mg/ml soluţie injectabilă
s.c. rompharm company s.r.l. - sugammadex sodium - soluţie injectabilă - 100 mg/ml
România -
română -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
gammanorm 165 mg/ml
octapharma ab - suedia - imunoglobulina umana normala - sol. inj. subcutana - 165mg/ml - imunoglobuline imunoglobulina umana de origine umana
Uniunea Europeană -
română -
EMA (European Medicines Agency)
bridion
merck sharp & dohme b.v. - sugammadex - blocaj blocant - toate celelalte produse terapeutice - inversarea blocadei neuromusculare indusă de rocuroniu sau vecuroniu. pentru populația pediatrică: sugammadex este recomandat numai pentru reversia de rutină de rocuronium-a indus blocada la copii și adolescenți.
România -
română -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
sugammadex terapia 100 mg/ml
synthon hispania, s.l. - spania - sugammadexum - sol. inj. - 100mg/ml - alte preparate terapeutice preparate antidot
România -
română -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
milgamma n
c.p.m. contractpharma gmbh & co. kg - germania - combinatii - caps. moi - vitamina b1 si combinatii cu vitamina b6 si b12 vitamina b1 in combinatii cu vit. b6 si/sau vit. b12